Mangoceuticals, Inc.
MGRX- Exchange
- Nasdaq
- Industry
- Services-Misc Health & Allied Services, NEC
- SEC CIK
- 0001938046
No open-market purchases or sales by Mangoceuticals, Inc. insiders were filed in the last 90 days; 18 institutions reported holding it in 13F filings for Q2 2026, worth $455.6K in total; no superinvestor holds it.
13F holders, Q4 2023
Institutional positions in Mangoceuticals, Inc. as of Dec 31, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 5
- −4 vs. Q3 2023
- Shares held
- 127.5K
- +5 (0.0%) vs. Q3 2023
- Total value
- $34.9K
- −$100.9K (−74.3%) vs. Q3 2023
- New holders
- 2
- 1 more added
- Sold out
- 6
- 1 more reduced
Compare with Q3 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting MGRX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 18 | $455.6K |
| Q1 2026 | 18 | $297.6K |
| Q4 2025 | 18 | $1.88M |
| Q3 2025 | 11 | $820.1K |
| Q2 2025 | 10 | $444.2K |
| Q1 2025 | 8 | $146.9K |
| Q4 2024 | 9 | $220.9K |
| Q3 2024 | 13 | $319.7K |
| Q2 2024 | 6 | $147.7K |
| Q1 2024 | 8 | $72.0K |
| Q4 2023 | 5 | $34.9K |
| Q3 2023 | 9 | $135.8K |
| Q2 2023 | 5 | $166.4K |
| Q1 2023 | 1 | $5.32K |
| Q4 2022 | 0 | $0 |
| Q3 2022 | 0 | $0 |
| Q2 2022 | 0 | $0 |
| Q1 2022 | 0 | $0 |
| Q4 2021 | 0 | $0 |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q4 2023
Shares, value and share of portfolio for each institution holding Mangoceuticals, Inc.; share changes are against Q3 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Renaissance Technologies LLC | 30,458 | $8.00K | 0.00% | +30,458 | New |
| McCollum Christoferson Group LLC | 27,700 | $7.67K | 0.00% | +16,400+145.1% | Added |
| Vanguard Capital Wealth Advisors | 25,000 | $6.92K | 0.01% | 00.0% | Unchanged |
| Citadel Advisors LLC | 22,311 | $6.18K | 0.00% | −24,865−52.7% | Reduced |
| Federation des caisses Desjardins du Quebec | 22,000 | $6.09K | 0.00% | +22,000 | New |
| Desjardins Global Asset Management Inc. | 0 | $0 | 0.00% | −127−100.0% | Sold out |
| Virtu Financial LLC | 0 | $0 | 0.00% | −23,482−100.0% | Sold out |
| Private Advisor Group, LLC | 0 | $0 | 0.00% | −10,200−100.0% | Sold out |
| Independent Advisor Alliance | 0 | $0 | 0.00% | −10,000−100.0% | Sold out |
| Bank of America Corp | 0 | $0 | 0.00% | −120−100.0% | Sold out |
| UBS Group AG | 0 | $0 | 0.00% | −59−100.0% | Sold out |